NON-COMPLEMENT-BINDING DE NOVO DONOR SPECIFIC ANTI-HLA ANTIBODIES AND KIDNEY ALLOGRAFT SURVIVAL

被引：0
|
作者：
Guidicelli, Gwendaline [1 ]
Guerville, Florent [1 ]
Lepreux, Sebastien [1 ]
Wiebe, Chris [2 ]
Thaunat, Olivier [3 ]
Duboiss, Valerie [4 ]
Visentin, Jonathan [1 ]
Bachelet, Thomas [1 ]
Morelon, Emmanuel [3 ]
Niderson, Peter [1 ]
Merville, Pierre [1 ]
Taupin, Jean-Luc [1 ]
Couzi, Lionel [1 ]
机构：
[1] CHU Bordeaux, Hop Pellegrin, Bordeaux, France
[2] Univ Manitoba, Winnipeg, MB R3T 2N2, Canada
[3] Hosp Civils Lyon, Hop Edouard Herriot, Lyon, France
[4] Etab Francais Sang Rhone Alpes, Lyon, France
来源：
TISSUE ANTIGENS | 2015年 / 85卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
O18
引用
收藏
页码：307 / 307
页数：1
相关论文
共 50 条
  • [31] C1Q BLOCKING EFFECTS OF NON-COMPLEMENT-BINDING DONOR SPECIFIC HLA-ANTIBODIES
    Honger, Gideon
    Amico, Patrizia
    Arnold, Marie-Luise
    Spriewald, Bernd M.
    Schaub, Stefan
    HLA, 2016, 87 (04) : 224 - 225
  • [32] An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies
    Premaud, Aurelie
    Filloux, Matthieu
    Gatault, Philippe
    Thierry, Antoine
    Buchler, Matthias
    Munteanu, Eliza
    Marquet, Pierre
    Essig, Marie
    Rousseau, Annick
    PLOS ONE, 2017, 12 (07):
  • [33] PREVALENCE AND CLINICAL IMPACT OF DE NOVO DONOR SPECIFIC ANTI-HLA ANTIBODIES (DN DSA) IN PEDIATRIC KIDNEY TRANSPLANTATION IN GREECE
    Fylaktou, Asimina
    Mitsioni, Andromachi
    Vittoraki, Angeliki
    Petasis, Georgios
    Zampetoglou, Argyroula
    Karava, Vasiliki
    Myserli, Evaggelia
    Vagiotas, Lampros
    Printza, Nikoleta
    Iniotaki, Aliki
    Fouzas, Ioannis
    TRANSPLANT INTERNATIONAL, 2019, 32 : 234 - 234
  • [34] Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study
    Castro, A.
    Malheiro, J.
    Tafulo, S.
    Dias, L.
    Martins, L. S.
    Fonseca, I.
    Beirao, I.
    Castro-Henriques, A.
    Cabrita, A.
    HLA, 2017, 90 (05) : 267 - 275
  • [35] IMPACT OF EARLY BLOOD TRANSFUSION AFTER KIDNEY TRANSPLANTATION ON THE INCIDENCE OF DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES
    Saito, Mitsuru
    Satoh, Shigeru
    Saito, Takuro
    Yamamoto, Ryohei
    Nara, Taketoshi
    Chiba, Syuji
    Kanda, Sohei
    Numakura, Kazuyuki
    Narita, Shintaro
    Inoue, Takamitsu
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2019, 201 (04) : E1043 - E1043
  • [36] DETERMINANTS OF SEVERE FIBROSIS IN KIDNEY ALLOGRAFT: MAJOR IMPACT OF CIRCULATING DONOR SPECIFIC ANTI-HLA ANTIBODIES
    Gosset, Clement
    Viglietti, Denis
    Rabant, Marion
    Loupy, Alexandre
    Lefaucheur, Carmen
    TRANSPLANT INTERNATIONAL, 2017, 30 : 246 - 246
  • [37] ROLE OF DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN KIDNEY GRAFT FAILURE: A CASE-CONTROL STUDY
    Malheiro, Jorge
    Martins, La Salete
    Campos, Andreia
    Abreu, Rui
    Tafulo, Sandra
    Fonseca, Isabel
    Dias, Leonidio
    Henriques, Antonio Castro
    TRANSPLANT INTERNATIONAL, 2015, 28 : 71 - 72
  • [38] Impact of de novo donor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas-kidney transplantation
    Malheiro, Jorge
    Martins, La Salete
    Tafulo, Sandra
    Dias, Leonidio
    Fonseca, Isabel
    Beirao, Idalina
    Castro-Henriques, Antonio
    Cabrita, Antonio
    TRANSPLANT INTERNATIONAL, 2016, 29 (02) : 173 - 183
  • [39] Complement-binding donor specific anti-HLA antibodies: Biomarker for immunologic risk stratification in pediatric kidney transplantation recipients
    Sigurjonsdottir, Vaka
    Chaudhuri, Abanti
    Grimm, Paul
    PEDIATRIC TRANSPLANTATION, 2022, 26
  • [40] Role of rituximab for isolated de novo donor specific anti-HLA antibodies in renal transplant recipients
    Schafer, Antonia
    Ferrai-Lacraz, Sylvie
    Villard, Jean
    Hadaya, Karine
    SWISS MEDICAL WEEKLY, 2019, : 17S - 17S
12345